FDA’s Abbreviated New Drug Application Process Explained: How Generic Drugs Get Approved
The FDA's Abbreviated New Drug Application (ANDA) process lets generic drugmakers prove their products work just like brand-name drugs - without repeating expensive clinical trials. This system saves U.S. patients $373 billion annually and powers 90% of prescriptions.